* Diebold Nixdorf Inc DBD.N DBD is expected to show a
fall in
quarterly revenue when it reports results on February 12 for
the period ending December 31 2024
* The North Canton Ohio-based company is expected to report
a
4.8% decrease in revenue to $987.768 million from $1.04 billion
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Diebold Nixdorf Inc is
for
earnings of $1.05 per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $62.50, above its last closing price of $44.54.
This summary was machine generated February 10 at 13:43 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)